The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM statement

9 Apr 2020 07:00

RNS Number : 2729J
Location Sciences Group PLC
09 April 2020
 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

AGM Statement

 

Location Sciences (AIM: LSAI), the leading location data verification company, is holding its Annual General Meeting ("AGM") at 9.00am today at 20 Eastbourne Terrace, Paddington London W2 6LG. Ahead of the formal business of the AGM, Kelvin Harrison, Non-Executive Chairman of Location Sciences, will make the following statement:.

 

"The COVID-19 pandemic is having a significant impact on businesses across the world and Location Sciences, while being a software company, is not immune to these effects. While half of our revenues are fixed monthly fees, and therefore relatively secure, the other half are based on the volume of location advertising.

 

"Location Sciences' existing customer base is largely within the QSR (quick service restaurants), retail and leisure sectors, which have all been significantly impacted by the UK Government's restrictions. Consequently, while Q1 performance was in-line with the Board's expectations, the Directors anticipate Q2 revenues to be lower than previously expected. However, the Company's annual revenues are typically heavily weighted towards Q4, therefore the Directors expect to recover some of those Q2 lost revenues as brands seek to make up lost ground in the latter part of 2020.

 

"Shareholders should take comfort that, as a cloud-based software business, Location Sciences, which operates in four locations globally, has not seen a material impact on its core operations or services. It is well placed to act on the opportunities it sees in the marketplace.

 

"One such opportunity is to use the Company's location technology and considerable knowhow to assist the UK Government in understanding the effects of its policies, as well as to be part of any track and trace COVID-19 solution. The Directors are actively working with the Company's partners, and reaching out directly to the UK Government, to inform its decision making. The ultimate aim is to be part of a technology solution to supress the spread of COVID-19 while allowing some form of normality to return to the economy and to everyday lives. The Directors will keep shareholders updated on any material developments in this regard.

 

"With Q2 revenues likely to be lower than previously expected, the Company has also undertaken certain cost cutting measures. These include putting the Company's marketing and business development budgets on hold until there is greater visibility on when revenues are expected to return to normal levels. There is also considerable effort going into product development, which runs alongside our MRC accreditation process. Consequently, our engineering teams have never been busier. Since the year end, the Company has moved some of its engineering and data science team to the Ukraine, which gives us access to high calibre talent at competitive rates, as well as a degree of flexibility when demand increases for customer deliverables. In combination with the rationalisation programme undertaken in H2 2019, there are now only 16 full time staff serving four global locations. The Directors will monitor the need for more cost cutting depending on how long it takes for revenues to return to previous levels.

 

"Lastly, and on a personal note, while the impact of the COVID-19 pandemic has been felt by businesses globally, the personal impact of those affected is by far the most significant. It is with great sadness that I report that one of our longstanding shareholders passed away from the virus on Monday. All our thoughts are with his family and friends at this time. Please take care and heed the Government's advice; by all pulling in the same direction we will get through this together."

 

For further information please contact: 

 

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

 

Shore Capital (Nomad and Joint Broker)

 

Tel: +44 (0)20 7408 4090

Tom Griffiths

 

David Coaten

 

 

 

Peterhouse Capital (Joint Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

 

 

 

Milk & Honey PR

 Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

The person making this notification on behalf of the Company is David Rae, Chief Financial Officer of the Company.

 

About Location Sciences

Location Sciences is the pre-eminent global location verification provider to the $190 billion digital advertising industry, working in partnership with brands, media agencies and suppliers to reduce ad wastage and improve the effectiveness of location-based advertising campaigns.

The digital advertising marketplace remains unregulated and unmonitored, with an estimated $19 billion wasted on ad fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUWSVRRWUSRAR
Date   Source Headline
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSResult of Broker Option
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
4th May 202111:05 amRNSSecond Price Monitoring Extn
4th May 202111:00 amRNSPrice Monitoring Extension
4th May 20219:05 amRNSSecond Price Monitoring Extn
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:00 amRNSProposed Fundraise of up to £3.85m - Notice of GM
23rd Apr 20212:05 pmRNSSecond Price Monitoring Extn
23rd Apr 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSFinal Results for the year ended 31 December 2020
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 202111:00 amRNSPrice Monitoring Extension
19th Feb 20213:36 pmRNSTR-1 Notification of major holdings
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 20219:05 amRNSSecond Price Monitoring Extn
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSTrading Update and Directorate Changes
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20214:40 pmRNSSecond Price Monitoring Extn
20th Jan 20214:35 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20204:41 pmRNSSecond Price Monitoring Extn
17th Dec 20204:35 pmRNSPrice Monitoring Extension
16th Dec 20204:41 pmRNSSecond Price Monitoring Extn
16th Dec 20204:36 pmRNSPrice Monitoring Extension
14th Dec 20207:00 amRNSPotential Defamation Action Against the Company
30th Nov 20207:00 amRNSNew Contract Win and Trading Update
5th Nov 20203:44 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSIssue of shares to directors in lieu of fees & TVR
1st Oct 20207:00 amRNSAppointment of Nominated Adviser
17th Sep 202012:43 pmRNSHalf-year Report - Replacement
15th Sep 20207:00 amRNSHalf-year Report
1st Sep 20209:05 amRNSSecond Price Monitoring Extn
1st Sep 20209:00 amRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSContract
27th Jul 20207:00 amRNSTrading Update
3rd Jul 202011:05 amRNSSecond Price Monitoring Extn
3rd Jul 202011:00 amRNSPrice Monitoring Extension
1st Jul 202010:02 amRNSIssue of Equity and Total Voting Rights
16th Jun 202010:36 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.